Synthesis, Characterization, and Applications of Ammonium/Phosphonium Chitosan Derivatives for Investigative DNA Interactions by Wyatt, Quinton Kirk
BearWorks 
MSU Graduate Theses 
Summer 2018 
Synthesis, Characterization, and Applications of Ammonium/
Phosphonium Chitosan Derivatives for Investigative DNA 
Interactions 
Quinton Kirk Wyatt 
Missouri State University, Wyatt116374@live.missouristate.edu 
As with any intellectual project, the content and views expressed in this thesis may be 
considered objectionable by some readers. However, this student-scholar’s work has been 
judged to have academic value by the student’s thesis committee members trained in the 
discipline. The content and views expressed in this thesis are those of the student-scholar and 
are not endorsed by Missouri State University, its Graduate College, or its employees. 
Follow this and additional works at: https://bearworks.missouristate.edu/theses 
 Part of the Organic Chemistry Commons 
Recommended Citation 
Wyatt, Quinton Kirk, "Synthesis, Characterization, and Applications of Ammonium/Phosphonium Chitosan 
Derivatives for Investigative DNA Interactions" (2018). MSU Graduate Theses. 3288. 
https://bearworks.missouristate.edu/theses/3288 
This article or document was made available through BearWorks, the institutional repository of Missouri State 
University. The work contained in it may be protected by copyright and require permission of the copyright holder 
for reuse or redistribution. 
For more information, please contact BearWorks@library.missouristate.edu. 
  
 
SYNTHESIS, CHARACTERIZATION, AND APPLICATIONS OF 
AMMONIUM/PHOSPHONIUM CHITOSAN DERIVATIVES FOR 
INVESTIGATIVE DNA INTERACTIONS  
 
 
A Masters Thesis 
Presented to 
The Graduate College of 
Missouri State University 
 
 
In Partial Fulfillment 
Of the Requirements for the Degree 
Master of Science, Chemistry 
 
 
 
By 
Quinton K. Wyatt  
August 2018  
  
 ii 
SYNTHESIS, CHARACTERIZATION, AND APPLICATIONS OF 
AMMONIUM/PHOSPHONIUM CHITOSAN DERIVATIVES FOR 
INVESTIGATIVE DNA INTERACTIONS  
Chemistry 
Missouri State University, August 2018 
Master of Science 
Quinton K. Wyatt 
  
ABSTRACT 
Chitosan is examined as a non-viral vector capable of efficient gene delivery due 
to its favorable properties such as biodegradability, biocompatibility, and is non-toxic to 
mammalian cells. Cell modifications and vector permeability are enhanced in non-viral 
vectors that incorporate electrostatic interactions. This work synthesizes cationic (N+, P+) 
chitosan derivatives, to enhance electrostatic interactions towards nucleotides, using 
amide coupling agents EDC and HOBt. The final chitosan derivatives will bear cationic 
functional groups (N+, P+) with various alkyl groups (Me, Et, Pr, Ph) to examine their 
affinities to nucleotides and antifungal properties. mPEG grafted cationic chitosan 
derivatives were also synthesized to examine enhanced cell permeability. 1H NMR and 
FT-IR analysis are implemented to observe coupling of cationic ligands to chitosan and 
examine electron withdrawing effects of changing cationic groups. Turbidity studies were 
conducted to test chitosan derivatives for pH-dependent solubility. Changes in chitosans 
stability through loss of intramolecular interactions after ligand coupling was analyzed 
using TGA-DTG. CD and agarose gel electrophoreses were used to observe cationic 
chitosan derivatives affinity to nucleotides. Fluorescence Microscopy and Yeast Growth 
Assays examined anti-fungal properties of cationic derivatives. This work aims to 
investigate ammonium and phosphonium chitosan derivatives as a viable gene therapy 
candidate capable of enhanced affinity toward nucleotides.  
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CHAPTER 1. INTRODUCTION 
 
1.1. Chitin and Chitosan 
Chitin is the most abundant nitrogen-bearing organic compound and second most 
abundant polysaccharide found in nature.1,2 Its polymer chain is comprised of linear β-
(1,4)-linked N-acetyl glucosamine units, as seen in Figure1.3,4 The most common sources 
of chitin are crustaceans, shrimp, and crab shells, through demineralization and 
deproteinization.1,5 By the late 1950’s, professor C. Rought discovered chitosan by 
boiling chitin in concentrated alkaline solution, removing the N-acetyl groups (Figure 1), 
a process known as deacetylation.6,7 The deacetylation of chitin decreases this hydrogen 
bonding affect which decreases the molecular stability of the polymer chain compared to 
other polysaccharides such as cellulose.8,9 Chitin and chitosan are very similar polymers 
with various degrees of N-acetylated glucosamine units. The primary distinction between 
chitin and chitosan is the percent of acetyl groups remaining along the polymer chain. 
These two polymers, chitin, and chitosan, are a polymer blend where both N-
deacetylated, and N-acetyl glucosamine units are arranged throughout the length of the 
polymer.9 Unlike chitosan, chitin exhibits intramolecular hydrogen bonding through its 
acetyl and hydroxyl groups giving it a three-dimensional α-helices structure.3,10 When 
more than 50% of N-glucosamine units have an acetyl group present, then the polymer is 
chitin. When 50% or more of acetyl groups have been removed, the polymer is named 
chitosan. The degree of acetylation (DA) is the determining factor that distinguishes their 
names and properties.  
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Figure 1. Displays chitin being deacetylated by a deacetylase into chitosan.  
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Although chitosan’s structure is similar to that of other polysaccharides such as 
cellulose, it does not share many of its properties. Chitosan is insoluble in both organic 
and neutral to basic aqueous solvents. It was discovered that chitin with a DA less than 
sixty percent is soluble in dilute, acid solutions.1 At pH 6, the free amino groups found on 
chitosan’s N-deacetylated units begin to protonate, which slowly increases solubility. The 
increased solubility at lower pH’s allows for synthetic modifications to take place in 
solution. The protonation of free amino groups at lower pH’s allows for the formation of 
ionic cross-linking with multivalent ions.1 Like cellulose, chitosan has secondary and 
primary hydroxyl groups, which, once in solution, can be synthetically modified. The 
ability to synthetically alter chitosan’s amino and hydroxyl groups gives rise to a variety 
of applications ranging from soaps, cosmetics, water treatment, protein separation, gene 
delivery, and cancer treatments.1,4,11-20 
The applications of chitosan can be dictated by two main factors, DA and its 
molecular weight (MW). The DA and MW allow for specific physicochemical 
interactions making chitosan a suitable non-viral vector.1 DA can determine many of 
chitosan’s physical and chemical characteristics. The lower percentage of DA, the more 
available amino groups are present for modifications and protonation.  
The stability of chitin’s α-helix structure is disrupted by a lower percentage of DA 
and an increase in protonation of free amino groups. The disruption of intramolecular 
interactions allows for greater solvation and cationic interactions. When DA is greater 
than sixty percent, intramolecular hydrogen bonding and hydrophobic methyl groups 
make chitin insoluble in water.1,5,21 As DA decreases, the solubility of chitin increases 
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with decreasing pH. With lower DA, chitin is less sterically hindered and has less 
intramolecular interactions.5,21,22  
The microbial degradation of chitosan is correlated to two main factors: the DA 
and distribution of N-acetylated glucosamine units throughout the polymer chain. Lee et 
al.13 observed that chitosan’s degradation process rapidly declines after DA reaches lower 
than 30%. Similarly, the work of Aiba et al.12 concluded that chitosan with homogenous 
distribution of N-acetylated glucosamine units was less susceptible to degradation within 
lysosomal space.13 Controlling DA and distribution of N-acetylated glucosamine units 
affects chitosan’s ability to degrade within biological systems.13 
Like DA, MW significantly affects chitosan’s function in a variety of applications 
including burn healing, coagulation of pollutants, lowering blood cholesterol levels, 
enhancing drug dissolution, control of viscosity and improving crop yields.1,23 The MW 
has been reported to influence the growth of E. coli. Higher MW prevented E. coli. 
growth, while lower MW promoted it.24 Sodium nitrite (NaNO2) can be used to 
depolymerize chitosan controllably, allowing for a wide variety of different MW 
chitosan.24  
The MW of chitosan can determine the strength of interaction between DNA and 
chitosan. When electrostatic attraction occurs between protonated chitosan and DNA in 
acidic solution, higher MW chitosan can wrap around short double-stranded DNA and 
create a stronger interaction through entanglement.25 Low MW chitosan has been proven 
to be less effective at condensing short double-stranded DNA due to lack of this 
entanglement effect.1,26 These electrostatic interactions between DNA and chitosan are 
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generated by the protonation of chitosan’s free amino groups. However, this interaction is 
reversed at increasing the pH.  
Chitosan may be chemically modified to bear pH-independent cationic groups 
that can provide sustained interactions with short double-stranded DNA through a broad 
pH range.24 Controlling the positive to negative charge ratio (+/-) determines the degree 
of complexation of short double-stranded DNA when utilizing modified chitosan (of any 
MW). Modifying chitosan to contain cationic functional groups that are not dependent on 
pH can provide a means for chitosan to become a viable non-viral vector suitable for 
gene therapy.  
 
1.2. Chitosan Modification 
Modifications to chitosan to improve solubility in neutral conditions were 
previously investigated.1 Chitosan derivatives that bear various functional groups were 
prepared for a wide variety of applications which can be seen in Figure 2.1,27-33 Chitosan’s 
amino and primary hydroxyl groups allow chemical modification that can lead to an 
increase in solubility and affinity to nucleotides. Although chitosan is non-toxic to 
mammalian cells on its own, the addition of cationic functional groups to its polymer 
chain can increase toxicity.34 Chitosan derivatives incorporating cationic triphenyl groups 
into their structure have been shown to be toxic to mammalian cells.35  
The coupling of carboxylic acids to amino groups to form a more stabilized amide 
was subjected to rigorous research, and many new methods have been developed in 
recent years.36 The coupling of carboxylic acids to amino groups requires a preliminary 
activation step to create a stable intermediate that is more reactive toward amino groups.  
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Figure 2. Various chemical modifications of chitosan and their applications. 
Modifications have been made to the amino and primary hydroxyl groups.   
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In 1995, Nakajima et al.37 conducted experiments where altered carbodiimides were used 
to observe the effects on coupling efficiency. N,N'-dicyclohexylcarbodiimide (DCC) and 
1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC) were reacted with various 
nucleophiles to observe the reaction mechanism. In both cases (EDC and DCC), the rate-
limiting step was the formation of O-acylisourea, where the fully-protonated 
carbodiimide and the carboxylate ligand react to form a reactive intermediate. The O-
acylisourea complex is very reactive and short-lived in solution.36 At a pH lower than six, 
the intermediate hydrolizes reforming the carboxylic acid ligand and a deactivated EDC-
urea. At pH's between 6-8, the intermediate remains in solution long enough to encounter 
amino groups and undergo successful coupling. Although coupling with EDC and DCC 
has proven successful, many new additives have been studied to improve coupling 
efficiency. Hydroxybenzotriazole (HOBt) has been used in carbodiimide reaction 
schemes to stabilize the O-acylisourea intermediate, as seen in Figure 3. HOBt attacks the 
activated EDC-carboxy intermediate and forms a more stable intermediate that can 
remain in solution for an extended period of time, increasing the overall efficiency of the 
EDC/HOBt coupling scheme.36 The linking of functionalized carboxylic acids to 
chitosan’s primary amines has been investigated using EDC and HOBt.31,34 Using water-
soluble EDC, these modifications to chitosan can take place at room temperature under 
open air conditions. Using EDC followed by NHS or HOBt allows for cationic 
modification to chitosan making it more efficient for short double-stranded DNA 
interactions.37, 38  
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1.3. PEGylation 
PEGylation can be referred to as the coupling of polyethylene glycol (PEG) to 
other materials such as proteins or therapeutic vectors. Chitosan’s ability to interact with 
DNA has been improved through several modifications including PEGylation.38 Coupling 
of PEG to chitosan produces conjugates with reduced toxicity, and increased stability in 
aqueous media.39 The incorporation of PEG into many pharmaceutical applications, 
including gene therapy, is not surprising and is often encouraged.40 
 PEG-grafted chitosan has been prepared to lower toxicity of certain cationic 
chitosan derivatives and increase water solubility.39 Jiang et al.34 synthesized PEG-grafted 
Figure 3. Reaction mechanism of EDC and HOBt coupling carboxylic acid ligand to 
chitosan. 
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chitosan using methoxy PEG-nitro phenol carbonate and chitosan.40 PEG-grafted non-
viral vectors have been shown to stabilize complexation of short double-stranded DNA 
through shielding of the positive charges present on modified vectors. These vectors 
displayed higher solubility and complexation with short double-stranded DNA compared 
to non-PEG-grafted vectors.40 
PEG is one of the few hydrophilic polymers approved by the Food Drug 
Association (FDA) and has proven to play a vital role in biomedical and biotechnical 
fields. PEG has been used in a variety of applications ranging from cosmetics to polymer-
based drug delivery systems.39 PEGs are classified as linear or branched polyether 
compounds that are often found in a variety of molecular weights ranging from 3 to 
40,000 g/mol.39 Low molecular weight PEGs have lower melting points and are liquids at 
room temperature, while higher molecular weight PEGs have high melting points and are 
crystalline at room temperature. The most commonly used PEG is methoxy polyethylene 
glycol (mPEG), where one hydroxyl group has been converted into a methoxy group.39 
PEGs have been shown to be soluble in many organic solvents including, but not limited 
to, benzene, acetone, acetonitrile, methanol, and methylene chloride.39 The addition of 
PEG to medication and gene delivery vectors increases solubility which, in turn, 
increases their overall efficiency.  
 
1.4. Gene Therapy 
Chitin and chitosan were investigated for their applications in gene therapy since 
the early 1990’s when their structures were identified through infrared spectroscopy (IR). 
Chitin and chitosan are among the non-viral vectors heavily researched for gene delivery 
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due to their low toxicity in mammalian cells and naturally high abundance.1 Therapeutic 
fields have extensively researched gene therapy for over twenty years.1,31 Restored 
function to diseased genes by the addition of new genetic material has been previously 
reported.1,29 These methods have also been used as a research tool to investigate inherited 
single gene disorders.29 Gene delivery vectors, or vehicles, are needed to transfer new 
genetic materials into or near the desired therapeutic sites. The transfer of new genetic 
material can occur through techniques such as ex vivo, in vivo, or in situ.1  
Gene therapy’s main approaches utilize viral and non-viral vectors.3 Viral gene 
delivery utilizes viruses to infect cells with the modified genetic material. Viruses can be 
modified to stop their reproductive cycle by removing genetic sequencing needed for 
reproduction. However, they still require sequences for binding and gene delivery to be 
useful.33 Commonly used viral vectors include retrovirus1,41,42 adenovirus,1,4 adeno-
associated viruses,43 herpes virus44 and vaccinia virus1,45. Each viral vector listed above 
has been incorporated into its own unique application. A few of these viruses listed above 
can produce sustained gene expression, but only in cells that divide. Others are just as 
effective against non-dividing cells without integrating into their host cell chromosome.35 
Mutations in the cell can occur through the integration of viral DNA into the genomes of 
the cell while using viral gene delivery systems, which can lead to safety concerns.33 
The safety concerns of viral gene delivery began to grow after the accidental 
death of a patient using gene therapy for immune deficiency.34 The fear of using viral 
vectors resulted in increased interest in non-viral vectors. Non-viral vectors can deliver 
large fragments of genetic material to mammalian cells comparable to that of viral 
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vectors.34 Non-viral vectors have proven successful, but are far less effective than viral 
vectors in transfecting mammalian cells.46  
Many approaches have been investigated for improving non-viral vectors for gene 
therapy. Amongst cationic polymers investigated, dendrimers and short chain, oligomers 
have been found to meet the pharmaceutical standard for human use.47,48 Dendrimers 
have shown to form complexes with pDNA (polyplexes), and are regarded as one of the 
most effective non-viral vectors.49 Although dendrimers seem to have been the research 
standard for DNA interaction, there have been recent studies that have raised concern 
over their toxicity within biological systems.50,51 Decreasing the molecular weight and 
lowering the degree of branching of these dendrimers have been shown to only slightly 
lower the toxicity in biological systems.52-54 Cationic polymers that can be formed in 
long-chain fashion or polycationic-spherical balls have shown to have increased 
interaction with pDNA.52-55 Short-chain polymers, such as chitosan oligomers 14 units or 
shorter, have been shown to have weaker interactions and lower overall stability.50,51 
Chitosan and its family of linear polysaccharides have been proposed as biocompatible 
gene delivery vectors that can be tailored for electrostatic interactions. Studies have 
shown that chitosan exhibits low cytotoxicity within mammalian cells and displays 
viability in gene therapy.52-56 In the research so far conducted on chitosan’s interaction 
with DNA with cationic derivatives, high molecular weight chitosan has been shown to 
exhibit the highest complexation and stability and delays the release of pDNA.57-61  
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1.5. Anti-Yeast and Anti-Microbial 
There has been increasing concern regarding resistance of microbial pathogens to 
drug treatments. Although drug-resistant microbial pathogens have mostly been 
controlled for the latter half of the 20th century, they can cause infections or diseases in 
animals, plants, or humans.62 Microbial pathogens that have increased resistance to drug 
treatments can ultimately threaten human health and social development.62 Bacteria, 
viruses, and fungi have contributed to more than one-fourth of global deaths annually, 
due to outbreaks of infectious diseases.63-65 Microbial pathogens have many ways to 
spread, and controlling them is increasingly difficult. The widespread overuse of 
antibiotics and disinfectants has led to development of new strains of antimicrobial-
resistant microbial pathogens.66-68 There has been an urgent demand for researching new 
techniques of increasing the effectiveness of  anti-yeast and anti-microbial agents on 
microbial pathogens.  
Antimicrobials have mainly consisted of natural or low molecular weight 
compounds that are susceptible to resistance, which can often lead to toxicity in the 
human body due to biological diffusion.69,70 Polymeric antimicrobials have been used for 
their compatibility within biological systems and lower susceptibility to resistance. These 
polymers are self-stabilizing and can be used for long-term while remaining viable 
antimicrobials.66-68 Polymer materials used for antimicrobials characteristically inherently 
have long lasting durability and are environmentally friendly.65-70 The moieties that were 
extensively researched are those bearing quaternary ammonium salts and quaternary 
phosphonium salts. The cationic species have been shown to create complexations with 
cell membranes and DNA to inhibit cell growth.71 These cationic groups have been 
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investigated previously as disinfectant products and have displayed that ammonium salt 
were more effective and used more often than their phosphonium analogs.68 One research 
group is conducting polymeric anti-yeast studies modified chitosan polymers to bear 
three different cationic functional groups.71 Ammonium and phosphonium groups were 
the only two of the three groups that displayed antimicrobial properties. The 
antimicrobial activities of these cationic species of chitosan were evaluated through the 
cut plug method of treating bacteria and fungi.71 Phosphonium cationic derivatives 
displayed a higher activity against the microbes than did the ammonium derivatives. 
More research is necessary to synthesis cationic chitosan derivatives that can successfully 
inhibit microbe growth and reproduction.  
 
1.6. Previous Work  
Previous research has shown the use of ammonium, phosphonium, and mPEG to 
increase solubility and electrostatic interactions with DNA in aqueous solutions. 
Integrating these properties into our work could potentially lead to a viable non-viral 
vector suitable for gene therapy. Shi et al.66 research group developed pH dependent 
chitosan derivatives that revealed strong binding abilities between carboxymethyl 
chitosan derivatives and plasmid DNA.72 Imidazole carboxymethyl chitosan derivatives 
were synthesized to increase transfection efficiency within HEK293T cells. Chitosan 
derivatives bearing pH-dependent functional groups which maintained water solubility 
were the precursors to formally charged chitosan derivatives. Research conducted by Tan 
et al.60 used chitosan phosphonium derivatives to analyze their viability as antifungal 
agents.73 Their work concluded that phosphonium derivatives could enhance anti-fungal 
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activity compared to ammonium analogs, however, their work was not reproducible in 
our lab. Their procedure used chloroacetic chloride that was added dropwise into an 
aqueous solution that contained deacetylated chitosan and reacted for 12 hours. After 
conducting this experiment ourselves several times, it was clear that these results were 
not reproducible. Qian et al.37 also utilized phosphonium derivatives, but in conjunction 
with HeLa cells instead of fungal cells used by Tan et al.60 Phosphonium compounds 
were observed interacting with DNA while maintaining cell viability up to 200 µg/ml. 
Qian et al.37 research protocol established a successful synthesis route for coupling 
carboxylic acids to primary amines without using 1% acetic acid to solubilize the 
reactants. Their procedure used hydroxybenzotriazole (HOBt) and 1-ethyl-3-(3-
dimethylaminopropyl) carbodiimide (EDC) rather than the more commonly used N-
hydroxysuccinimide (NHS), as the coupling agent. Wang et al.68 modifications to 
chitosan were similar to that of Qian et al.37, but with slight changes to the carbon linker 
between chitosan and phosphonium functional groups. This work is among many others 
that show a strong interaction between phosphonium derivatives and short double-
stranded DNA while maintaining mammalian cell viability. Layek et al.69 synthesized 
cationic chitosan derivatives containing hydrophobic regions that self-assemble into 
micelles upon interaction with DNA. This work created increased interest for its viable 
application as a gene carrier capable of efficient gene therapy. A series of work done by 
Lin et al.70 and Casettari et al.71 incorporated mPEG into chitosan derivatives and 
observed lower toxicity, and increased permeability, in mammalian cells. Research 
conducted by Fréchet et al.72 observed that the alkyl groups on phosphonium cations play 
an essential role in the overall interaction with DNA and toxicity in HeLa cells.73,74 
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Among the phosphonium groups tested, triethylphosphonium was found to be less toxic 
in HeLa cells up to 350 µg/ml compared to trimethylphosphonium, which was found to 
be toxic at 100 µg/ml. This work also revealed a distinction between ammonium and 
phosphonium interactions with siRNA. Phosphonium complexed siRNA at much lower 
concentrations than ammonium, which required up to ten times the concertation. 
 
1.7. Purpose of Work 
This research aims to synthesize ammonium and phosphonium chitosan 
derivatives, seen in Figure 4, to observe and characterize their antimicrobial properties 
and interaction with short double-stranded DNA and yeast cells. 
In this work, ammonium and phosphonium chitosan derivatives, seen in Figure 4, 
were prepared by modifying previously reported methods, to enhance complexation of 
short double-stranded DNA. Tri(methyl, ethyl, and propyl)ammonium and tri(ethyl, and 
phenyl)phosphonium carboxy ligands were prepared form halogenated propionic acid or 
ethyl esters. The prepared ammonium and phosphonium ligands were coupled to 95% 
DA chitosan using EDC and HOBt. The final cationic chitosan derivatives were 
examined for their antifungal properties, and affinity towards nucleotides, using NMR, 
FT-IR, CD, TGA, degree of substitution, agarose gel electrophoresis, turbidity, yeast 
growth assay, florescense microscopy studies. The cationic derivatives with the most 
enhanced interactions compared to unmodified chitosan were subjected to PEGylations to 
observe changes in the interactions between nucleotides and yeast cells. 
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Figure 4. Ammonium, phosphonium, and PEGylated chitosan derivatives prepared in 
this work. 
 
  
17 
 
CHAPTER 2. EXPERIMENTAL METHODS 
 
2.1. Materials and Instrumentation  
2.1.1. Materials. Chitosan 95% deacetylated (medical grade) was purchased from 
Bonding Chemical Co.. Ethyl-4-bromobutyrate, ethyl bromoacetate, chloroacetyl 
chloride, 3-chloropropionyl chloride, trimethylamine, triethylamine, tripropylamine, were 
purchased from Sigma-Aldrich. 1-Ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC) 
was purchased from Chem Empex. DMSO, DMSO-d6, D2O, hydroxybenzotriazole 
(HOBt), N-hydroxysuccinimide (NHS), methoxy polyethylene glycol 5000 were 
purchased from Alfa Aesar. 24-mer Dickerson DNA was a gift from Dr. Gary Meints. Dr. 
Kyoungtae Kim provided yeast cells. Sam Kasson, from Dr. Keiichi Yoshimatsu's lab, 
supplied fluorescein isothiocyanate.  
2.1.2. Nuclear magnetic resonance (NMR). Ammonium/phosphonium 
carboxylic acid ligands and chitosan derivatives were subjected to 1H NMR spectroscopy 
studies using a Varian 400 MHz NMR spectrometer for data collection and third-party 
ACD Labs 1D NMR processor software for data analysis. All 1H NMR studies were 
conducted at 25o C in D2O or DMSO. D2O was used for all chitosan derivatives, while 
DMSO was used for all ammonium/phosphonium carboxylic acid ligands. All samples 
prepared for 1H NMR analysis contained 1 mg of chitosan derivative and 700 μL of 
solvent. The solution was then placed into Branson 2510 ultrasonic bath for one hour to 
ensure the samples were completely dissolved in the solvent, and then analyzed. The 
parameters of each study were held constant with the solvent volume of 700 μL, 5 second 
acquisition time, 5-second relaxation, 90o pulse angle, and auto gain control. Correction 
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values were based on literature values of each solvent’s chemical shift rather than TMS. 
The results of these studies can be seen in Appendix A. 
2.1.3. Fourier-transform infrared spectroscopy (FT-IR). Chitosan and its 
derivatives were subjected to Fourier-transform infrared spectroscopy studies to confirm 
coupling of functionalized carboxylic acid ligands to N-glucosamine units. A Bruker 
Vertex 70 FT-IR was used for data collection, using Bruker OPUS 7.5. software for 
instrument control and data analysis. All FT-IR experiments where conducted using KBr 
pellets in which 1 mg of a sample was added to 30 mg of KBr. The parameters of each 
study were held constant with a wavenumber range of 4000-400 cm-1, 2 cm-1 resolution, 
100 scans, and automatic atmospheric correction. The results of these studies can be seen 
in Appendix B. 
2.1.4. Agarose Gel Electrophoresis. Agarose gel electrophoresis was carried out 
in pH 7.4 tris acetate EDTG (TAE) buffer using 2% agarose gels, 2 µL of 80 µM 
Dickerson 24-mer DNA, 5 µL of concentrated ethidium bromide, 2 µL of loading dye, 
and 10 µL of chitosan derivatives. The molar cationic charge of chitosan derivatives was 
obtained by comparing degree of substitution (DS) to the average N-glucosamine unit 
molecular weight after carboxy ligand coupling. Molar electrostatic ratios were 
determined to compare moles of cationic chitosan derivative to 24-mer Dickerson DNA 
in each well, resulting in (+/-) ratios. The (+/-) ratio solutions used ranged from 16x-
0.25x. 2 µL of 80 µM 24-mer Dickerson DNA was added to each well, followed by a 
series of solutions containing increased charge ratios using cationic chitosan derivatives. 
Visualization was done using a short-range UV lamp, ethidium bromide filter camera 
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lens, and Microsoft digital image capturing software. The results of these studies can be 
seen in Appendix D. 
2.1.5. Yeast Growth Assay. Yeast cells with an initial optical density (OD) of 
0.06 were placed into a 96 well plate with increasing concertation of chitosan derivatives 
ranging from 0.1 to 1000 µg/mL. The prepared samples were incubated for 24 hours at 25 
oC while shaking at 600 rpm. The OD of each well was read at 490 nm every ten minutes 
over the duration of the experiment using a BioTek ELx808 microplate reader. The data 
of each chitosan derivative was collected and compared using Microsoft Excel. The 
results of these studies can be seen in appendix G. 
2.1.6. Circular Dichroism (CD). CD Analysis was conducted using a Jasco J-
815 spectrometer coupled with a PFD-425s single position peltier. The samples were 
loaded into a cuvette with a path length of 1mm and max volume of 400 µL. 100 µL of 
10 mM phosphate-buffered saline (PBS) (pH: 7.4) was loaded into the cuvette and used 
as background measurement. After the background scan was complete, 2 µL of 80 µM 
Dickerson Drew Dodecamer (DDD) was added to the previous 100 µL of 10 mM PBS 
sample and scanned. When both background and DDD measurements were collected, a 
series of 10 µL of increasing charge ratios using cationic chitosan derivatives were added 
to 100 µL of 10 mM PBS and 2 µL of 80 µM DDD. The charge ratios used ranged from 
1 to 48 (+/-) and were prepared as previously established in agarose gel electrophoresis 
analysis. Each sample was scanned 6 times at a speed of 50 nm/min at room temperature. 
Data points were collected every 0.025 nm. The results were then analyzed using the 
Jasco Data Analysis tool and overlaid in Microsoft Excel 2016. Further analysis and final 
results can be found in Results and Discussion section, and Appendix E. 
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2.1.7. Turbidity. Turbidity data were collected using a Varian Cary 50 UV-Vis 
spectrophotometer with fiber optic probe. Turbidity instrument was unavailable for true 
measurement. 1.00 mg of chitosan and its derivatives were dissolved in 5.00 mL of 1% 
aqueous acetic acid. The pH was gradually increased using 0.1 M NaOH until a pH of 13 
was obtained. Data was collected at various pH ranges between 3.0 and 13.0 using a 
Fischer Science 810 series pH meter. The wavelength of 600 nm was used in %T 
evaluation after running all samples through full range scan from 190 nm to 800 nm to 
verify no conflicting signals. Turbidity results can be seen in Figure 26. 
2.1.8. Thermogravimetric analysis (TGA). Thermogravimetric analysis was 
conducted using a TA Instrument Q600 Thermogravimetric Analyzer. The TGA scale 
was tared using two empty crucibles: one as a reference, and the second for the sample. 
The sample crucible was torched with a flame and cooled before taring the instrument. 
After taring, the sample crucible was then loaded with a chitosan derivative, and the 
starting mass was recorded. The procedure for TGA used a ramp temperature of 20 
oC/min with an initial temperature of 25 oC and the final temperature of 600 oC. Nitrogen 
was used as a purge gas flowing at 200 mL/s. Further analysis of TGA data was 
conducted using TA Universal software, and the results can be found in Results and 
Discussion section, and in Appendix C. 
2.1.9. Fluorescence Microscopy Studies. Yeast cells were incubated overnight, 
and their OD measured before analyzing with FITC tagged chitosan derivatives. 10.0 μL 
of 10.0 mM FITC solution was added to 1.0 μL of 100.0 mM chitosan derivative and 
shaken for one hour. The solution was then centrifuged into a pellet, and the solvent was 
removed. The pellet was resuspended using acetone, vortexed for 1 minute, and then 
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centrifuged down again. The FITC tagged derivatives were washed in this manner 3 
times. Yeast cells (250 μL, OD 0.30) were placed in 1.0 µg/1.00 mL concentrations of 
FITC tagged chitosan derivatives and incubated for 4 hours. The resulting solution after 4 
hours was centrifuged down into a pellet and washed three times with glucose media to 
remove free FITC tagged polymer. The final pellet was suspended in 100 μL and 
vortexed for 1 min. Soon after, 2 μL of the suspended cells were removed, placed on a 
glass slide, and put under a microscope. The final images were obtained using a 3i 
lambda XL GFP 488 lamp for excitation, an Orca R2 wide-lens microscope for 
visualization, and Slidebook Image Capturing software for digitally capturing the images. 
These images can be found in the Results and Discussion, and in Appendix F.  
 
2.2. Synthesis of Ammonium Ligands 
The procedure was carried out following the protocol established by Yousuke 
Ono et al.73 5.0 mL of 95% ethanol and 10.5 mmol of ethyl bromoacetate, or ethyl 4-
bromobutyrate, was added to a 25 mL round bottom flask. While stirring, 11.4 mmol of 
trialkylamine (N(R)3) was addetable d dropwise to the ethanol solution. The reaction was 
stirred vigorously and refluxed using a heating mantle for 15 hours.73 The solution was 
then cooled to room temperature before ethanol was evaporated using a Heidolph model 
036000820 rotary evaporator, yielding a clear oily residue. Without purification, the oily 
residue was dissolved in 100 mL of 2M HCl solution and refluxed for 24 hours. The 
reaction was allowed to cool to room temperature before the solvent was removed at 70 
oC using the rotary evaporator.73 This resulted in an orange oily residue. The oily residue 
was dissolved in 1 mL of 95 % ethanol and added dropwise into 50 mL of ethyl acetate 
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then cooled in an ice bath for 1 hour. This solution was placed on the rotary evaporator 
and crystallization of cationic carboxylic acids occurred. The solvent was filtered off 
using vacuum filtration, and the crystals were washed with three portions of ethyl acetate. 
The final trialkyl carboxylic acid ligands were placed in a vacuum desiccator and allowed 
to dry for three days. The final products were then examined using 1H NMR 
spectroscopy. The reaction scheme for the synthesis of ammonium carboxylic acid and 
TEPB ligands is shown in Figure 5.  
2.3. Synthesis of Phosphonium Ligands 
Freshly recrystallized chloroacetic acid, or iodopropionic acid, (5.3 mmol) was 
dissolved in triethlyphosphine (5.3 mmol) and placed into a 15 mL microwave tube.73 
Once fully dissolved, the tube was placed into a CEM Discover SP microwave reactor 
and subjected to 35 Watts for 30 minutes under nitrogen. The reaction was then washed 
with diethyl ether and dried for three days. The final products were (1-carboxymethyl) 
triethylphosphonium chloride (TEPA) or (2-carboxyethyl) triethylphosphonium chloride 
(TEPPr). The reaction scheme for TEPA and TEPPr can be seen in Figure 6. Synthesis of 
(3-carboxypropyl)triethylphosphonium chloride (TEPB) was conducted using the 
Figure 5. Reaction scheme for synthesizing ammonium/phosphonium carboxylic acid 
ligands 
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previously established procedure for the synthesis of ammonium carboxylic acid 
ligands.73 
 
2.4. Synthesis of Ammonium/Phosphonium Chitosan Derivatives  
The procedure was carried out following the protocol established by Qian et al.37 
1.24 mmol of ammonium/phosphonium carboxylic acid ligand was added to 0.350 g 
(1.83 mmol) of EDC, and 0.350 g (2.30mmol) of HOBt in 15 mL of DMSO, and alotted 
one hour to dissolve. Once completely dissolved, 0.200 g (1.24 mmol) of 95% 
deacetylated chitosan was placed into the reaction mixture along with 15 mL of DI water, 
stirred till homogenous, and reacted for 24 hours. After 24 hours, an additional 0.350 g of 
EDC was added to the reaction mixture and stirred for 12 more hours. After 12 hours, the 
reaction mixture (30 mL) was precipitated, dropwise, in 300 mL of acetone and was 
shaken for 15 minutes. The acetone wash solution was then filtered using vacuum 
filtration. The resulting filter cake was then returned to the original acetone wash flask 
then washed with 300 mL of 95% ethanol for 15 minutes and filtered again. After 
washing the product three times with ethanol, the filter cake was submerged in diethyl 
ether and stirred for 15 minutes and then allowed to gravity filter for one hour followed 
Figure 6. Reaction scheme using microwave reactor to synthesize phosphonium 
acetic, or propionic, carboxylic acid ligands 
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by 30 minutes of air drying under vacuum filtration. The final products were 
ammonium/phosphonium carboxylic acid substituted chitosan derivatives.  
 
2.5. PEGylation of Ammonium/Phosphonium Chitosan Derivatives  
Following a slightly modified protocol established in section 2.2. (shown in 
Figure 7), 1.00 mmol of freshly synthesized ammonium/phosphonium chitosan derivative 
(as prepared on page 25-26) was dissolved in 15 mL of DI water. In a separate 50 mL 
flask, 1.0 g (0.2 mmol) of mPEG-5000 acetic acid (prepared by other graduate students 
within our lab ) was dissolved in 15 mL DMSO. 0.350 g (1.83 mmol) of EDC and 0.350 
g (2.30mmol) of HOBt was added to the DMSO reaction vessel and stirred for one hour 
(or until completely dissolved). The two solutions were combined and stirred vigorously 
for 24 hours. The DMSO/water reaction mixture was placed in a 14Kda-16Kda dialysis 
membrane tube and dialyzed for three days. The dialyzed product was then lyophilized 
for three days, until dry. The dry product was then crushed into fine powder and soaked 
in methylene chloride for one hour to remove all un-grafted mPEG-5000 acetic acid. The 
methylene chloride solution was filtered off using vacuum filtration and then washed 
Figure 7. Reaction scheme using EDC and HOBt to graft mPEG-acid to chitosan. 
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three more times. Then the mPEG-g-chitosan derivatives were dried at 50 oC using a 
vacuum oven. The final products were PEGylated ammonium/phosphonium chitosan 
derivatives. 
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CHAPTER 3. RESULTS AND DISCUSSION 
 
3.1. 1H NMR Analysis  
3.1.1. Ammonium and Phosphonium Carboxylic Acid Ligands. Ammonium 
carboxylic acid ligands, phosphonium carboxylic acid ligands, and chitosan derivatives 
were analyzed using 1H NMR spectroscopy. The results of each study can be viewed in 
Appendix A. The integral lines, and values, are indicated in red while the proton signals 
are labeled with numbers above the spectra. After each sample was dried at 50 oC in a 
vacuum oven for 12 hours, 1 mg of sample was dissolved in 700 µL of DMSO, or D2O, 
and placed into an NMR tube. All chemical shift values for ammonium carboxylic acid 
ligands are compiled in Table 1. 
The spectrum consisting of TMAA signals displays peaks at 4.33 ppm (2H) which 
is assigned to the two protons on signal labeled 1 in Figure 8, while the peak at 3.19 ppm 
(9H) corresponds to the nine protons located on the signal labeled 2. The integration 
values, labeled in red, for signals 1 and 2 are proportional indicating that successful (1:1) 
substitution of bromide for trimethylamine occurred. There was no acetic carboxylic acid 
peak observed downfield for all acetic ligands. 
The TEAA spectrum is similar to TMAA with one additional peak. The signal 
furthest downfield at 4.18 ppm (2H) is assigned to the protons located on signal labeled 1 
in Figure 9. When comparing the alpha carbons chemical shift (labeled 1) on TEAA and 
TMAA, their value shifts from 4.33 to 4.18 ppm, displaying a delocalization of an 
electron withdrawing effect brought on by increased carbon length of the 
triethylammonium group. The signal observed at 3.45 ppm (6H) is assigned to six 
protons located on the triethylammonium, (N+(CH2CH3)3) and is labeled 2. The signal  
  
27 
 
 
  
Ligand Name Abbreviation Yield 1H NMR ppm DMSO-d6 
(1-Carboxymethyl) 
trimethylammonium 
chloride 
TMAA  (73.8%) 4.33 (2H, -CH2N+(CH3)3), 3.19 
(9H, -N+(CH3)3) 
(1-Carboxymethyl) 
triethylammonium 
chloride 
TEAA  (62.8%) 4.18 (2H, -CH2N+(CH2CH3)3), 3.44 
(6H, -N+(CH2CH3)3), 1.16 (9H, -
N+(CH2CH3)3 
(1-Carboxymethyl) 
tripropylammonium 
chloride 
TPAA  (70.3%) 3.29 (2H, HO2CCH2-), 2.96 (6H, -
N+(CH2CH2CH3)3), 1.62 (6H, -
N+(CH2CH2CH3)3), 0.85 (9H, -
N+(CH2CH2CH3)3 
(3-Carboxypropyl) 
trimethylammonium 
chloride 
TMAB  (88.9%) 12.31 (1H, HO2CCH2-), 3.01 (9H, -
CH2CH2CH2N(CH3)3), 2.71 (2H, -
CH2CH2CH2N+(CH3)3), 2.26 (2H, -
CH2CH2CH2N+(CH3)3 ), 1.88 (2H, -
CH2CH2CH2N+(CH3)3 
(3-Carboxypropyl) 
triethylammonium 
chloride 
TEAB  (82.6%) 12.31 (1H, HO2CCH2-), 3.20 (9H, -
N+(CH2CH3)3), 3.07 (2H, -
CH2N+(CH2CH3)3), 2.31 (2H, -
CH2CH2CH2N+-), 1.75 (2H, -
CH2CH2CH2N+-), 1.13 (2H, -
N+(CH2CH2)3 
(3-Carboxypropyl) 
tripropylammonium 
chloride 
TPAB  (39.2%) 12.31 (1H, HO2CCH2-), 3.20 (6H, -
N+(CH2CH2CH3)3), 3.07 (2H, -
CH2N+(CH2CH2CH3)3), 2.31 (2H, -
CH2CH2CH2N+-), 1.75 (2H, -
CH2CH2CH2N+- ), 1.13 (9H, -
N+(CH2CH2CH3 )3 
Table 1. Table of synthesized ammonium carboxylic acid ligands with their 
abbreviations, yield, and 1H NMR ppm assignments using DMSOd6 
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observed at 1.16 ppm (9H) is assigned to the nine protons found on 
triethylammonium, (N+(CH2CH3)3) and is labeled 3. The integration values for these 
signals are labeled in red in Figure 9. These values are (1:1) indicating proportional 
substitution of bromide for triethylamine. 
The signals observed for TPAA in Figure 10, again, are similar to the other 
ammonium acetic acid ligands prepared. The signal at 3.29 ppm (2H) corresponds with 
the protons found on the alpha carbon, labeled 1. This signal demonstrates a continued 
delocalization of electron withdrawing effect as the alkyl substituents lengthen. The 
signal observed at 2.96 ppm (6H) is assigned to the protons labeled 2, followed by the 
signal at 1.62 (6H)ppm and is labeled 3. The nine protons associated with the three 
methyl groups on signal 4 appear at 0.85 ppm (9H). The integration values for TPAB are 
shown in Figure 10, and again, these values are proportional (1:1) indicating no other 
impurities are present in the NMR sample.  
The spectrum of TMAB is shown in Figure 11. The proton signal found at 12.31 
ppm (1H) is assigned to the carboxylic acid grouped labeled 5. The signal labeled 3 is 
located at 3.26 ppm (2H) and is the CH2 closest to the carboxy group. The peak observed 
at 3.01 ppm (9H) is assigned to the nine protons located on the signal labeled 4. The 
signals for protons 2 and 3 are located at 2.26-1.86 ppm (4H).  
The spectrum of TEAB, shown in Figure 12, displays a carboxylic acid peak 
labeled 6 at 12.30 ppm (1H). The chemical shift values of the carbon chain found on 
TEAB, are similar to that of TMAB and can be assigned accordingly 3.09 ppm (2H label 
3), 2.31 ppm (2H label 1), 1.75 ppm (2H label 2). However, unlike that of TMAB, TEAB 
has one new peak emerge at 3.20 ppm (6H label 4) that is assigned to the -CH2- closest to  
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Figure 9. Integrated 1H 
NMR of TEAA. 
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DMSO-d6 
 
Figure 8. Integrated 1H 
NMR of TMAA. 
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Figure 10. integrated 1H 
NMR of TPAA 
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DMSO 
 
  
30 
 
N+. The nine protons assigned to the methyl groups are labeled 5 and are observed at 1.13 
ppm (9H label 5). The butanoic ligands display similar delocalization of the electron 
withdrawing effect like that of acetic acid ligands.  
The proton signals for TPAB were similar to that of TEAB and TMAB except for 
the addition of one new peak. Like that of TEAB and TMAB, the butanoic carbon chain 
signals are located at 3.09 ppm, 2.29ppm, and 1.77 ppm corresponding to labels 3, 1, and 
2, shown in Figure 13. A clear carboxylic acid peak is present at 12.31 ppm (1H label 7) 
indicating successful ester hydrolysis. The peak labeled 4, 5, and 6 are the ammonium 
tripropyl group and have chemicals shift values of 3.12 ppm (6H, label 4), 1.60 ppm (6H, 
label 5), and 0.85 ppm (9H, label 6). 
The phosphonium carboxylic acid ligands were examined in the same way and 
values are found in table 2. TEPA proton signals were examined and labeled 1, 2, and 3 
shown in Figure 14. Label 1 is assigned to the protons located between the carboxyl and 
phosphonium groups and has a chemical shift value of 3.75 ppm (2H, d). The 
protonsignals for the triethyl group bound to P+ have chemical shift values of (6H) and 
(9H) and are labeled 2 and 3, respectively. 
TEPPr proton signals were examined and labeled 1, 2, 3, and 4, shown in Figure 
15. Labels 1 and 2 are assigned to the protons located between the carboxyl and 
phosphonium groups and have a chemical shift value of 2.59 ppm (2H) and 2.39 ppm 
(2H). The proton signals for the triethyl group bound to P+ have chemical shift values of 
2.23 ppm (6H) and 1.10 ppm(9H) and are labeled 3 and 4, respectively. The signal 
located at 12.59 ppm (1H) is labeled 5 and is assigned to the carboxylic acid.  
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Ligand Name Abbreviation Yield 1H NMR ppm DMSOd6 
(1-Carboxymethyl) 
triethylphosphonium 
chloride 
TEPA 
 
90.0% 
3.75 (2H, -H2P+(CH2CH3)3), 2.30 
(6H, HO2CCH2 P+(CH2CH3)3), 1.10 
(9H, -P+(CH2CH3)3 
(2-Carboxyethyl) 
triethylphosphonium 
chloride 
TEPPr 
 
75.3% 
12.58 (1H, HO2CCH2-), 2.55 (2H, -
CH2CH2P+-), 2.39 (2H, -CH2 
P+(CH2CH3)3), 2.23 (6H, -
P+(CH2CH3)3), 1.08 (9H, -
P+(CH2CH3)3 
(3-Carboxypropyl) 
triethylphosphonium 
chloride 
TEPB 
 
76.1% 
12.16 (1H, HO2CCH2CH2-), 2.36 
(2H, HO2CCH2CH2CH2-), 2.26 (2H, -
CH2 P+(CH2CH3)3), 2.22 (6H, -
P+(CH2CH3)3), 1.67 (2H, -
CH2CH2P+(CH2CH3)3), 1.08 (9H, -
P+(CH2CH3)3 
Table 2. Table of synthesized phosphonium carboxylic acid ligands with their 
abbreviations, yield, and 1H NMR ppm assignments using DMSOd6 
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Figure 13. 1H NMR 
spectrum of TPAB 
Figure 12. 1H NMR 
spectrum of TEAB 
Figure 11. 1H NMR 
spectrum of TMAB 
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The spectrum of TEPB, shown in Figure 16, was examined and labeled 1, 2, 3, 4 
and 5. Labels 1, 2, and 3 are assigned to the protons located between the carboxyl and 
phosphonium groups and have a chemical shift value at 2.36 ppm (2H), 2.16 ppm (2H), 
and 1.67 ppm (2H). The proton signals for the triethyl group bound to P+ have chemical 
shift values of 2.2 ppm (6H) and 1.10 ppm(9H) and are labeled 4 and 5, respectively. The 
signal located at 12.31 ppm (1H) is labeled 6 and is assigned to the carboxylic acid.  
3.1.2 Ammonium and Phosphonium Chitosan Derivatives. All synthesized 
derivatives displayed characteristic chitosan signals as evidenced by the broad peaks 
located from 4.00-3.30 ppm, shown in Figure 17, and they are assigned to the protons 
found on Chitosans glucosamine ring (labeled C2-C6). All ammonium and phosphonium 
chitosan derivatives ppm values are shown in Table 3 and 4.  
TMAB-CS’s -CH2- signals labeled b, c, and d are found between the amide and 
ammonium group and have a chemical shift values of 2.29 ppm (2H), 1.96 ppm (2H), and 
3.21 ppm (2H), as shown in Figure 17. The proton signals for the trimethyl group found 
on N+ have a chemical shift value of 2.96 ppm (9H) and are labeled e.  
For TEAB-CS, the -CH2- signals, also labeled b, c, and d, are found between the 
amide and ammonium group and have a chemical shift values of 2.28 ppm (2H), 1.85 
ppm (2H), and 3.04 ppm (2H) ), as shown in Figure 17. The proton signals for the triethyl 
group found on N+ have chemical shift values of 3.15 ppm (6H) and 1.11 ppm (9H) and 
are labeled e and f. 
For TPAB-CS, the -CH2- signals, once more labeled b, c, and d, are found 
between the amide and ammonium group and have a chemical shift values of 2.26 ppm 
(2H), 1.85 ppm (2H), and 2.74 ppm (2H) ), as shown in Figure 17 The proton signals for  
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Figure 14. 1H NMR 
spectrum of TEPA  
Figure 15. 1H NMR 
spectrum of TEPPr  
Figure 16. 1H NMR 
spectrum of TEPB 
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Compound Name Abbreviation DS 1H NMR ppm D2O 
2-(N-4-
trimethylammonium) 
butanamide chitosan 
chloride 
TMAB-CS 
 
50.0% 
4.45 (1H, anomeric H), 3.80-3.30 
(6H, C2-C6 H’s), 3.21 (2H, -
CH2CH2N+(CH3)), 2.98 (9H, -
CH2CH2N+(CH3)3), 2.29 (2H, -
OCH2CH2CH2N+(CH3)), 1.96 (2H, 
-CH2CH2N+(CH3).  
2-(N-4-
triethylammonium) 
butanamide chitosan 
chloride 
TEAB-CS 43.0% 
4.43 (1H, anomeric H), 4.0-3.25 
(6H, C2-C6 H’s), 3.15 (6H, -
N+(CH2CH3)3), 3.04 (2H, -
CH2CH2N+(CH2CH3)3), 2.66 (1-
2H, -2H-NHCOCH2-), 2.28 (2H, -
OCH2CH2CH2 N+-, 1.84 (2H, -
CH2CH2N+( CH2CH3)3, 1.11 (9H, -
CH2CH2N+( CH2CH3)3 
2-(N-4-
tripropylammonium) 
butanamide chitosan 
chloride 
TPAB-CS 26.0% 
4.48 (1H, C1-Anomaric H), 4.0-
3.25 (6H, C2-C6 H’s), 3.04 (6H, -
N+(CH2CH2CH3)3), 2.74 (2H, -
CH2N+(CH2CH2CH3)3) , 2.26 (2H, 
-CH2CH2CH2N+-), 1.85 (2H, -
CH2CH2 N+-), 1.55 (6H, -
N+(CH2CH2CH3)3), 0.79 (9H, -
N+(CH2CH2CH3)3 
Table 3. Table of synthesized ammonium chitosan derivatives with their 
abbreviations, yield (DS), and 1H NMR ppm assignments using D2O 
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Compound Name Abbreviation Yield 
1H NMR ppm D2O 
2-(N-3-
triethylphosphonium) 
propionamide 
chitosan chloride 
TEPPr-CS 
 
19.0% 
4.48 (1H, anomeric H), 4.0-2.66 
(6H, C2-C6 H’s,2H-NH), 2.55 (2H, 
-CH2CH2N+(CH2CH3)3), 2.38 (2H, 
-CH2N+(CH2CH3)3) , 2.11 (6H, -
CH2N+(CH2CH3)3), 1.09 (9H, -CH2 
N+(CH2CH3)3 
2-(N-4-
triethylphosphonium) 
butanamide chitosan 
chloride 
TEPB-CS 21.0% 
4.82 (1H, anomeric H), 4.0-2.66 
(6H, C2-C6 H’s ,2H-NH), 2.35 (2H, 
-OCH2CH2CH2N+ -), 2.07 (6H, -
N+(CH2CH3)3) , 2.07 (2H, -
CH2N+(CH2CH3)3), 1.75 (2H, -
CH2CH2N+(CH2CH3)3), 1.08 (9H, - 
N+(CH2CH3)3 
2-(N-5-
triphenylphosphoniu
m) pentanamide 
chitosan chloride 
TPPP-CS 42.0% 
7.65-7.50 (15H, P+Ph3-CH2CH2-), 
4.39 (1H, anomeric H), 4.0-2.66 
(6H, C2-C6 H’s ,2H-NH), 3.13 (2H, 
P+Ph3-CH2CH2-), 2.16 (2H, P+Ph3-
CH2CH2CH2CH2-), 1.60 (4H, 
P+Ph3-CH2CH2CH2-) 
Table 4. Table of synthesized phosphonium chitosan derivatives with their 
abbreviations, yield (DS), and 1H NMR ppm assignments using D2O 
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Figure 17. 1H NMR spectra of 1) TMAB-CS, 2) TEAB-CS, 3) TPAB-CS, 4) TEPB-
CS, 5) TEPPr-CS, and 6) TPPP-CS, using D2O. 
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the tripropyl group found on N+ have chemical shift values of 3.04 ppm (6H), 1.55 ppm 
(6H), and 0.79 ppm (9H) and are labeled e, f, and g. 
The phosphonium derivatives display similar chemical shift values compared to 
ammonium derivatives except for the -CH2- located on the triethyl group attached to P+. 
These -CH2- protons experience far less deshielding from P+ compared to N+ and are 
observed having a 1.04 ppm difference in chemical shift value. As for TPPP-CS 
derivative, the 1H NMR spectrum and ppm values are previously reported in scientific 
literature, can be seen in Table 2 and Figure 17. 
For TEPPr-CS, the -CH2- signals labeled b, and c are found between the amide 
and phosphonium group and have chemical shift values of 2.55 ppm (2H), and 2.38 ppm 
(2H), as shown in Figure 17. The proton signals for the triethyl group found on P+ have 
chemical shift values of 2.11 ppm (6H) and 1.08 ppm (9H) and are labeled d and e. 
For TEPB-CS, the -CH2- signals, also labeled b, c, and d, are found between the 
amide and ammonium group and have chemical shift values of 2.35 ppm (2H), 1.75 ppm 
(2H), and 2.07 ppm (2H) ), as shown in Figure 17 The proton signals for the triethyl 
group found on P+ have chemical shift values of 2.07 ppm (6H) and 1.08 ppm (9H) and 
are labeled e and f. 
3.1.3 PEGylated Ammonium, and Phosphonium, Chitosan Derivatives. 
Compound TEAB-CS, TEPB-CS, or TPPP-CS was reacted with mPEG-acid (MW: 
5000), EDC, and HOBt to synthesis PEGylated chitosan derivatives. TEPB-CS and 
TEAB-CS were selected because they are direct analogs of each other and can provide a 
direct comparison between ammonium and phosphonium interaction before and after 
PEGylation. TPPP-CS already reported in scientific literature was found to be toxic to 
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mammalian cells by Quian et al.37 and was selected to undergo PEGylation to evaluate 
PEGs ability to lower toxicity. All 1H NMR spectra of PEGylated compounds have the 
same chemical shift values as their non-PEGylated derivatives, as shown in Table 5,  
except for PEG polymer chain located at 3.55 ppm (448H) and its methoxy at 3.20 ppm 
(3H). PEGylated 1H NMR spectra can be seen in Figure 18. 
3.1.4 Discussion. 1H NMR was conducted for confirmation of successful 
ammonium/phosphonium carboxy ligand coupling to chitosan. EDC and HOBt were 
observed in 1H NMR spectra until after the third wash cycle. Accurate integrations and 
spectra comparisons could be analyzed once EDC and HOBt were successfully removed. 
Integration values and peak assignments became more difficult to analyze after coupling 
due to the loss of resolution and peak broadening caused by the increased polydispersity 
and chitosan’s long polymer backbone. All peak assignments are found in the 
experimental section, and in Appendix A. Ammonium carboxy ligands displayed a much 
higher deshielding effect than did phosphonium groups. In the case of triethylammonium 
carboxy ligands, the CH2 associated with N+(CH2CH3)3 was observed at 3.15 ppm; and 
displays more of an inductive effect from its neighboring N+ than that of its P+ analog. 
Comparing the same CH2 found in P+(CH2CH3)3, the chemical shift is more upfield at 2.0 
ppm, displaying less of an inductive effect on neighboring carbons adjacent to P+, and 
leading to a more localized cationic charge. The localization of cationic charge is 
expected to be more observable in future studies, including agarose gel electrophoresis. 
1H NMR was only conducted on ammonium/phosphonium propionic, butanoic, and 
pentanoic chitosan derivatives. Ammonium/phosphonium acetic acid chitosan derivatives 
proved to be unsuccessful in coupling to chitosan with EDC and HOBt. Although acetic 
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Compound Name Abbreviation DS 1H NMR ppm D2O 
2-(N-4-
triethylphosphonium) 
butanamide mPEG-g-
chitosan chloride 
 
TEPB-mPEG-
CS 
1.67% 
4.82 (1H, anomeric H), 4.0-2.66 
(6H, C2-C6 H’s ,2H-NH), 3.55 
(mPEG backbone), 3.23 (3H, -
OCH3), 2.35 (2H, -
CH2CH2CH2P+-), 2.07 (6H, -
CH2P+(CH2CH3)3) , 2.07 (2H, -
CH2CH2P+(CH2CH3)3), 1.75 (2H, 
-CH2CH2P+(CH2CH3)3), 1.08 
(9H, -CH2 P+(CH2CH3)3 
2-(N-4-
triethylammonium) 
butanamide mPEG-g-
chitosan chloride 
TEAB- 
mPEG-CS 
5.73% 
4.43 (1H, anomeric H), 4.0-3.25 
(6H, C2-C6 H’s), 3.55 (mPEG 
backbone), 3.23 (3H, -OCH3) 
3.15 (2H, -N+(CH2CH3)3), 3.04 
(6H, -CH2CH2N+(CH2CH3)3), 
2.66 (1-2H, -
CH2CH2N+(CH2CH3)3), 2.28 (2H, 
-CH2CH2CH2 N+( CH2CH3)3, 1.84 
(2H, -CH2CH2N+( CH2CH3)3, 
1.11 (9H, -CH2N+( CH2CH3)3 
2-(N-5-
triphenylphosphonium) 
pentanamide mPEG-g-
chitosan chloride 
TPPP- 
mPEG-CS 
2.76% 
7.65-7.50 (15H, P+Ph3-
CH2CH2CH2CH2-), 4.39 (1H, 
anomeric H), 4.0-2.66 (6H, C2-
C6 H’s ,2H-NH), 3.55 (mPEG 
backbone), 3.23 (3H, -OCH3), 
3.13 (2H, P+-CH2CH2CH2CH2-), 
2.16 (2H, Ph3-CH2CH2CH2CH2-), 
1.60 (4H, Ph3-CH2CH2CH2CH2-) 
Table 5. Table of PEGylated ammonium, or phosphonium, chitosan derivatives with 
their abbreviations, yield (DS), and 1H NMR ppm assignments using D2O. 
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acid ligands are small, the reactive carboxyl group is sterically hindered to a significant 
degree by the ammonium/phosphonium group directly adjacent. More efficient coupling 
was observed as the carbon chain increases on the carboxy ligand, as seen in Table 6. 
Variations in ammonium alkyl groups also displayed a correlation in degree of 
substitution. All substituion reactions contained same ratio of ligand to chitosan and 
reaction conditions. TMAB-CS had the highest coupling efficiency (DS=50%), compared 
to that of TEAB-CS and TPAB-CS, due to its long carbon chain and decreased steric 
hindrance from the trimethyl groups. Compared to TMAB-CS and TEAB-CS, TPAB-CS 
displayed the lowest coupling efficiency ( DS=23%) as its bulky propyl substituents 
created increased steric hindrance. 
Figure 18. 1H NMR spectra of 1) TEAB-mPEG-g-CS, 2) TEPB-mPEG-g-CS, and 3) 
TPPP-mPEG-g-CS, using D2O 
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Compound 
Degree of 
Substitution 
2-(N-3-triethylphosphonium) propionamide chitosan chloride 
(TEPPr-CS) 
19% P+ 
2-(N-4-triethylphosphonium) butanamide chitosan chloride 
(TEPB-CS) 
21% P+ 
2-(N-5-triphenylphosphonium) pentanamide chitosan chloride 
(TPPP-CS) 
42% P+ 
2-(N-4-trimethylammonium) butanamide chitosan chloride 
(TMAB-CS) 
50% N+ 
2-(N-4-triethylammonium) butanamide chitosan chloride 
(TEAB-CS) 
43% N+ 
2-(N-4-tripropylammonium) butanamide chitosan chloride 
(TPAB-CS) 
26% N+ 
2-(N-4-triethylphosphonium) butanamide mPEG-g-chitosan 
chloride  
(TEPB-mPEG-CS) 
1.6% mPEG 
2-(N-4-triethylammonium) butanamide mPEG-g-chitosan 
chloride  
(TEAB-mPEG-CS) 
5.73% mPEG 
2-(N-5-triphenylphosphonium) pentanamide mPEG-g-chitosan 
chloride 
(TPPP-mPEG-CS) 
2.76% mPEG 
Table 6. Calculated degree of substitution (DS) for all chitosan derivatives 
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3.2. FT-IR Analysis 
FT-IR analysis was conducted on all ammonium and phosphonium chitosan 
derivatives to examine changes in spectra after cationic carboxyl substitution. 
Characteristic peaks corresponding to amide I and II formation observed near 
wavenumbers 1650 cm-1 and 1550 cm-1 were found for both ammonium and 
phosphonium derivatives as shown in Figure 19. C-N+ stretching was observed in all 
ammonium derivatives near wavenumber 1480 cm-1 and was consistent with C-N+ values 
found by Tan et al.67 C-P+ stretching was observed in all phosphonium derivatives 
between wavenumbers 1450 and 1410 cm-1 and was consistent with C-P+ values found by 
Qian et al.37 Characteristic wavenumbers for chitosan are observed at 3260 cm-1 and are 
assigned to the hydroxyl and amino groups found on carbons 3 and 6. C-H stretching was 
Figure 19. FT-IR spectra of TMAB-CS, TEAB-CS, TPAB-CS, TEPB-CS, TEPPr-CS, 
and TPPP-CS, showing C-P+ and C-N+ for synthesized chitosan derivatives. 
N+ 
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observed near wavenumber 2880 cm-1 for all chitosan derivatives. For all chitosan 
derivatives, an amide I signal associated with C=O stretching vibration is observed near 
wavenumber 1650 cm-1, while an amide II signal associated with N-H bending vibrations 
appears near wavenumber 1540 cm-1. 
 Strong C-O stretching frequencies associated to carbons 1, 3, 4, 5, and 6 were observed 
near wavenumber 1060 cm-1. PEGylated derivatives’ additional C-H, and C-O stretching 
causes a dramatic increase in intensity near wavenumbers 2867 cm-1 and 1060 cm-1, as 
shown in Apendix B. Characteristic chitosan derivative peaks were still observable after 
PEGylation indicating a low percentage of mPEG-acid substitution. 
 
3.3. Degree of Substitution  
Further characterization of chitosan and its derivatives relies on obtaining the 
degree of substitution (DS) of ammonium/phosphonium carboxy ligand and mPEG (MW: 
5000) acid to chitosan. The degree to which these derivatives are substituted affects their 
overall interaction with biological molecules. Ammonium/phosphonium ligands promote 
higher electrostatic interactions due to their formally-charged nitrogen or phosphorous. 
Adapting DS calculation protocol from Jaidee et al.44, 1H NMR was used to obtain final 
DS values. Using 1H NMR spectra, the degree of substitution can be obtained by 
comparing two independent integration values and the number of protons contributing to 
those values.49 In Figure 20, we found the acetyl groups DS by comparing both chitosans, 
and acetyl groups, integral values to their associated protons. Dividing the acetyl group’s 
integration value by the number of protons associated to that signal (3 protons), we obtain 
the integration value of 1 acetyl proton. Likewise, Dividing the chitosan polymer 
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integration value by the number of protons associated to that signal (6 protons, excluding 
the hydrogen attached to anomeric carbon), we obtain the integration value of 1 chitosan 
proton.  Then dividing the 1 acetyl proton value by the 1 chitosan proton value and 
multiplying it by 100, gives us the degree of substitution of acetyl groups found on 
chitosan. Following the equation set forth above and also found in Figure 21, we obtained 
DS for our starting material. The acetyl integration value of 3.00 should be divided by 3, 
(for there are three protons found on acetyl groups) leaving a value of 1. Then chitosans 
integration value of 128.59 should be divided by 6, (for the sum of protons on carbons 
C2-C6 is 6) leaving 21.43. Finally, dividing acetyls value of 1 by chitosans value of 21.43 
and multiplying by 100, we obtain a DS=4.66%. The DS percent value represents the 
 DS =
3.00 ÷ 3
128 .59 ÷6
× 100 = 4.66 % Acetylated  
 
  
 
DS =
3.00 ÷ 3
128 .59 ÷6
× 100 = 4.66 % Acetylated 
  
  
  
  
  
  
  
  
  
Figure 20. Calculation of degree of substitution (DS) using staring material 95% 
DA chitosan. Integral lines are in red and their values below the spectrum 
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percent of acetyl groups coupled to amino groups on chitosan. Thus, 4.66% of our 
starting material is acetylated. The chitosan shown in Figure 20 was purchased as 95% 
deacetylated chitosan from Bonding Chemical company.66 Comparing these two values 
of acetylation from our calculations and Bonding Company analysis, we were able to 
obtain the same degree of accuracy of substitution up to (0.34%).66  
 mPEG DS was calculated following an altered mathematical procedure is shown 
in Figure 22. DS values of PEGylated chitosan derivatives needed to incorporate the DS 
of the previous reaction product before the DS of the mPEG could be evaluated. The 
equation given in Figure 21 can be rearranged to solve for chitosans integration value 
using the previously calculated DS for that particular ammonium/phosphonium 
derivative, as seen in Figure 22. After calculating the integration value for chitosan, we 
can subtract this value from the overlapping integration values, of mPEG and chitosan, to 
isolate mPEG’s integration value. This value can be plugged in the equation found in 
Figure 21 to determine the DS of PEGyalted derivatives.  
The DS values obtained for both PEGylated and non-PEGylated derivatives were 
used in both CD and agarose gel electrophoresis. These DS values were used to calculate 
moles of positive charge for each chitosan derivative and their average molecular weight 
per unit after substitution reactions. Using these calculated values, we were able to obtain 
Figure 21. Equation used for calculating degree of substitution where Is is, integrated 
signal value for substituted ligand, Hs is number of protons associated to substituted 
ligand, and Ichitosan is the integrated signal value for chitosan protons (C2-C6 and -
CH2OH) 
  
47 
 
accurate charge to charge ratios for determining ammonium, and phosphonium, 
derivatives’ affinity to Dickerson Drew Dodecamer (DDD) B-form DNA.  
 
3.4. Agarose Gel Electrophoresis 
Agarose gel electrophoresis was used to examine ammonium and phosphonium 
chitosan derivatives’ ability to complex DDD B-form DNA. The concentration of DDD 
was calculated using the absorbance value from 260 nm collected by Varian Cary 50 UV-
Vis spectrophotometer and its extinction coefficient of 1.11 × 105 M−1cm−1 at 25o 
C.Using 24-mer DDD B-form DNA (consisting of 24 negatively charged phosphate 
groups), we were able to evaluate interactions using ammonium/phosphonium chitosan 
derivatives. All ratios established for electrophoresis are a charge to charge ratio 
determined by DS of each chitosan derivative. These ratios are written in (n)X notation,  
were “n” is whole number multiplied by 1 to 1 ratio of positive to negative charge (+/-). 
For all DNA-ammonium chitosan derivative complexes exceeding a ratio of 2X, we were 
able to observe complete complexation of DNA, evidenced by the fluorescence staying in 
the starting wells. Moving from the 2X ratio towards 0.25, we can observe a signal for 
free, uncomplexed DNA. When comparing ammonium chitosan derivatives affinities at 
Figure 22. equation used for calculating degree of substitution of PEGylated 
derivatives, where Is is, integrated signal value for substituted ligand, Hs is number of 
protons associated to substituted ligand, and Ichitosan is the integrated signal value 
for chitosan. After finding ∑ Ichitosan (2.6-4.0 ppm)  this value can be subtracted from the 
integration value for the PEGylated spectrum to isolate just the mPEGs integration 
value. 
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2X charge ratio, we can observe clear differences in cationic interaction between the 
different ammonium groups. At a charge ratio of 2X, TPAB-CS displayed the least 
affinity to DDD DNA, compared to TMAB-CS and TEAB-CS. TEAB-CS appeared to 
have the most effective interactions with DNA as evidenced by complete complexation at 
a charge ratio of 2X compared to TMAB-CS and TPAB-CS charge ratios of 4X, as seen 
in Figure 23. Attention should be drawn to the florescence that remain in the wells after 
complete complexation at 4X, 8X, and 16X. In the case of TPAB-CS, the fully-
complexed DNA in 4X charge ratio appeared to be pushed towards the front of the well, 
as seen in Figure 23. As for the wells containing charge ratios of 8X and 16X, the 
florescence can be observed drawn toward the back of the well. Completely complexed 
DNA was observed in the starting wells having an over all complexation charge, as 
evidenced by their postion in the startings wells. In the case of phosphonium derivatives, 
there were not only differing results from the ammonium groups, but the phosphonium 
groups had different outcomes amongst themselves. TEPPr-CS appears less soluble 
compared to TEPB-CS leading to a dramatic loss of complexation of DDD DNA across  
Figure 23. Agarose gel electrophoresis results of TMAB-CS, TEAB-CS, TPAB-CS, 
and TEPB-CS. Wells are in charge ratios of 1: 16x, 2: 8x, 3: 4x, 4: 2x, 5: 1x, 6: 0.5x, 
7: 0.25x, 8: Control 
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all charge ratios. Reaction conditions for TEPPr and chitosan coupling would have to be 
improved to increase solubility and the efficiency of DNA complexation at lower charge 
ratios. TPPP-CS displayed improved results when compared to ammonium derivatives; 
complete complexation occurs at a charge ratio of 2X; leaving little-to-no signal at 
concentration 1X. TEPB-CS had a more effective interaction than all other derivatives 
tested. Complete complexation using TEPB-CS occurred at a charge ratio of 1X. TEPB-
CS had a higher affinity for DDD DNA at charge ratios 0.5 and 0.25X when compared to 
all other chitosan derivatives. Due to a more localized charge, TEPB-CS complexes DNA 
more efficiently. This increase in efficiency could make phosphonium chitosan 
derivatives viable candidates for gene therapy.  
PEGylation of these compounds resulted in a severe loss of electrostatic 
interaction between chitosan derivatives and DNA, as seen in Figure 24. After 
PEGylation, TPPP-mPEG-g-CS and TEAB-mPEG-g-CS suffered a drastic loss in 
interaction with DDD compared to their previous un-PEGylated derivatives. The large 
size of mPEG-5000 increases steric hindrance to the already-bulky trialkyl chitosan 
derivatives. However, PEGylation of TEPB-CS resulted in only a slight loss of 
interaction with DDD. The DS for TEPB-CS was half that of TEAB-CS, and yet 
PEGylated TEPB-CS maintained high complexation of DDD DNA compared to  
PEGylated TEAB-CS. Although the PEGylated ammonium derivatives lack the same 
efficiency of un-PEGylated derivatives, electrostatic interaction leading to complete 
complexation can still be observed. 
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3.5. Turbidity 
Chitosan derivatives were analyzed for pH-dependent solubility using a Varian 
Cary 50 UV-Vis spectrophotometer at 600 nm. Values of %T were collected over an 
increasing pH range from 3-13. The data points for each study were plotted on a graph 
and can be seen in Figure 25. Turbidity results are used to determine the potential 
viability of chitosan derivatives that can remain soluble long-term in vivo. During the 
analysis, TPPP-mPEG-g-CS was the only derivative with a noticeable decrease in %T 
after pH 7. Although the decrease was gradual, the derivative did not aggregate or fall out  
of solution. TEPPr-CS exhibited a steady overall %T that was lower than all other 
derivatives tested, which may be correlated to the poor interaction with DDD during 
agarose gel electrophoresis. The turbidity analysis displayed a lack of pH-dependent  
Figure 24. Agarose gel electrophoresis results of TEAB-mPEG-g-CS and TEPB-
mPEG-g-CS. Wells are in charge ratios of 1: 16x, 2: 8x, 3: 4x, 4: 2x, 5: 1x, 6: 0.5x, 
7: 0.25x, 8: Control 
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solubility in the chitosan derivatives, ensuring that our products are not just protonated 
chitosan species.  
3.6. Thermogravimetric analysis (TGA) and Differential Thermogravimetric (DTG) 
It is known that intramolecular and intermolecular hydrogen bonding stabilizes 
fully acetylated chitin and 95% DA chitosan. most of these interactions are lost in 
carboxy substituted chitosan derivaitves.66 It has been well established that chitosan 
derivatives with increasing DS exhibit lower intermolecular stability when compared to 
low DS derivatives.66 Ammonium and phosphonium chitosan derivatives were analyzed 
using TGA, and their results displayed a clear correlation between increased DS and 
decreased thermal stability which were consistent with literature findings.67 
Figure 25. Turbidity analysis of all synthesized chitosan derivatives evaluated using 
%T at 600 nm. With an initial pH of 3, 0.1 M NaOH was added to increase pH till a 
value of 13 was obtained 
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Thermogravimetric analysis was conducted using a TA Instrument Q600 
Thermogravimetric analyzer on all chitosan derivatives to evaluate thermal stability after 
ammonium, phosphonium, and mPEG (MW: 5000) substitutions. All samples were 
subjected to thermal degradation starting at room temperature and ending at 600 oC using 
a ramp rate of 20 oC/min. Although the stability is lower due to the loss of hydrogen 
bonding interactions, the degradation process takes on new phases as different ligands are 
coupled to chitosan. Unmodified chitosan TGA displayed initial degradation beginning at 
265 oC, followed by a smooth decline until no further degradation phases were observed. 
The degradation phases for ammonium and phosphonium chitosan derivatives were close 
together making separate phases harder to distinguish. The TGA results for chitosan and 
its derivatives were converted to differential thermogravimetric (DTG) (%/oC) for more 
accurate comparisons.  
Changes in chitosan derivatives’ stability due to altered substituents is readily 
observed using DTG rather than unmodified TGA. DTG peaks indicate a high loss in 
weight % at a particular temperature. Using DTG, single- or multi-phase degradation is 
more easily observed compared to the cluttered signal of TGA, as seen in Figures 26 and 
27. All DTG results display an initial phase between 25-100 oC due to loss of water 
adsorbed to the starting material, which is not considered to be a degradation phase. 
Chitosan follows a single-phase degradation process displaying no secondary 
stabilization structure. TEAB-CS displayed a degradation process similar like that of 
chitosan where only one phase is observed. However, TEAB-CS’s degradation begins at 
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223 oC, which is 42 oC less than unmodified chitosan; indicating loss of intermolecular 
stabilization. Both TMAB-CS and TPAB-CS displayed a two-phase degradation process. 
Their first phases begin at 227 oC and 216 oC, indicating a loss of stabilization when 
compared to unsubstituted chitosan. Their second phases began at 239 oC and 259 oC and 
can be attributed to the ammonium ligands substitution. TEPB-CS displayed three phases 
of degradation and the lowest overall thermal stability. The first phase of TEPB-CS 
began at 205 oC which is significantly lower than that of unsubstituted chitosan beginning 
at 265 oC. TEAB-CS, TEPB-CS, and TPPP-CS were PEGylated to challenge the 
hypothesis of increased stability in mPEG grafted polymers.  
Figure 26. DTG of non-PEGylated ammonium, and phosphonium, chitosan 
derivatives was used to examine change in stability of chitosan’s polymer chain after 
carboxylic coupling reaction 
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There was an overall increase in stability, but not to the chitosan derivative’ s main 
polymer chain. Phase 1 for compounds TEAB-CS, TEPB-CS, and TPPP-CS still had 
decreased degradation temperatures of 193 oC, 229 oC, and 208 oC, respectively. 
However, these PEGylated derivatives displayed an additional phase beginning at 344 o 
C, 310 oC, and 338 oC; which can be assigned to the degradation of the mPEG backbone. 
Although there was increased stability with more of the weight percent being preserved 
until higher temperature, this was due only to the addition of mPEG (MW: 5000), and not 
to the stability of chitosan derivatives. Ammonium and phosphonium chitosan derivatives 
were analyzed using TGA, and DTG, and their results of the first degradation phase 
demonstrates a correlation between increased DS and decreased thermal stability.67  
Figure 27. DTG of PEGylated TEAB-CS, and TEPB-CS, derivative used to examine 
the change in stability of chitosan’s polymer chain after carboxylic and mPEG 
coupling reactions 
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3.7. Circular Dichroism (CD)  
CD analysis was conducted to observe electrostatic interaction with the 
nucleotides found in DDD DNA and chitosan derivatives. Jasco J-815 CD spectrometer 
evaluated the effects of chitosan and its derivatives on DDD's secondary structure, B-
form double-stranded DNA at 25 oC. The charge ratios used for CD analysis were 
prepared in the same manner as agarose gel electrophoresis. Unmodified chitosan and its 
derivatives do not produce a signal in the wavelengths being investigated. The positive 
and negative ellipticities of DDD are centered around 280 nm and 260 nm, and are in 
concordance with literature findings for B-form DNA.68-70 In Figure 28, the chitosan 
derivatives were examined at a charge ratio of 4x. It is at this charge ratio we examined 
complete complexation of DNA in all derivatives.  The greatest loss of B-form 
comformational normality was oberved with TPAB-CS. As charge ratios amongst the 
independent studies are increased, the loss of B-form conformational state is observed 
due to the complexation of chitosan derivative with DNA. Chitosan derivatives ’ 
interaction with DDD with increasing charge ratios are shown in Apendix E. As the +/- 
charge ratio is increased, the molar ellipticities of the DNA is suppressed; and the 
positive band near 280 nm is shifted. TPAB-CS displays the most significant increase in 
the signal of the negative band centered around 260 nm, and the most significant decrease 
of the positive band at 280 nm . All chitosan derivatives displayed interactions with 
DNA, as evidenced by the suppressed 260 nm (negative) signal and 280-290 nm 
(positive) signal.69,70 Although changes in intensities were observed at 200-220 nm, their 
interpretations are unclear, and were not used for investigating chitosan derivatives 
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interaction with DNA.69,70 Although there are no conclusive conformational changes 
from B to Z-form DNA, CD analysis did display an interaction between ammonium and 
phosphonium chitosan derivatives with DDD. 
3.8. Fluorescence Microscopy Studies 
To evaluate if yeast cells would internalize ammonium or phosphonium 
derivatives, fluorescence microscopy studies were conducted using a 3i Lambda XL GFP 
488 lamp for excitation of FITC, an Orca R2 wide-lens microscope for visualization of 
the cells, and Slidebook Image Capturing software for digitally capturing the images. The 
procedure used for preparing the cells with FITC tagged chitosan derivatives is outlined 
in section 2.1.9. In Figures 29 and 30, cells with FITC-tagged chitosan derivatives can be 
seen as a green hue. An intensity heat map was used to visualize the yeast cells  
Figure 28. CD analysis was conducted to examine complexation/interaction of 
ammonium, and phosphonium, chitosan derivatives with DDD DNA using 1-42X 
charge ratios. The non-PEGylated chitosan derivatives above represent complete 
complexation at charge ratio 4X 
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Figure 29. Fluorescence Microscopy results utilizing intensity heat mapping to 
vizualize FITC tagged derivatives TMAB-CS, TEAB-CS, TPAB-CS, and TEPB-CS 
Figure 30. Fluorescence Microscopy results utilizing intensity heat mapping to 
vizualize FITC tagged derivatives TEAB-mPEG-g-CS, TEPB-mPEG-g-CS, and 
TPPP-mPEG-g-CS 
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containing FITC-tagged chitosan derivatives. A new preparation procedure and 
visualization protocol for the internalization of FITC-tagged chitosan derivatives is being 
implemented in future studies to improve the accuracy of the results. Further 
investigations are underway to investigate the internalization of FITC-tagged chitosan 
 derivatives into mammalian cells. As for this study, the results can only conclude FITC 
tagged derivatives are adsorbed to the cell membrane or internalized. Neither result can 
be explicitly confirmed.  
 
3.9. Yeast Growth Assays 
 The antifungal properties of ammonium and phosphonium chitosan derivatives 
were examined using a BioTek ELx808 microplate reader and freshly inoculated yeast 
cells. The preparation procedure for yeast growth assays is found in section 2.1.5. The 
data collected was normalized by taking the final OD reading for each concentration, 
dividing it by the final OD of the control, and multiplying by 100. The results of each 
study were compiled into a plot and can be seen in Appendix G. The normalization of the 
data was necessary for accurate comparisons to be made between each sample. Figure 31 
displays a clear inhibition of yeast growth at just 5 μg/mL; while at 1 μg/mL, some 
samples increased growth. TEPB-CS displayed the greatest inhibition of yeast growth 
compared to TMAB-CS, TEAB-CS, and TPAB-CS. The promotion of yeast growth using 
TMAB-CS and TPAB-CS is currently unexplained and is being researched further. For 
all samples tested, no growth was observed at concentrations greater than 5 μg/mL. 
Future experiments will narrow the concentration between 1 and 5 μg/mL to discover an 
accurate inhibition cutoff.  
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Figure 31. Yeast growth assay conducted using TMAB-CS, TEAB, TPAB-CS, and 
TEPB-CS derivatives with concentrations of 0, 1, and 5 µg/mL to analize antifungal 
properties 
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CHAPTER 4. CONCLUSION 
 
In this work, ammonium and phosphonium chitosan derivatives (see page 16, 
Figure 4) have been synthesized and characterized by 1H NMR, FT-IR, TGA, CD, 
agarose gel electrophoreses, confocal microscopy, and yeast growth assays. Although 
some ammonium derivatives have been reported in the literature, to the best of our 
knowledge the synthesis and characterization of the derivatives made in this work have 
not yet been reported in the literature.  
TEPB-CS displayed the best interaction with Dickerson Drew Dodecamer DNA 
when compared against all ammonium derivatives synthesized. 1H NMR was able to 
display the localization of positive charge found on phosphoniums derivatives; while FT-
IR was able to display strong coupling of the cationic carboxy ligands to chitosan. 
Agarose gel electrophoreses observed that TEPB-CS was able to complex DDD at 1x 
concentration, compared to that of ammonium where complete complexation occurred at 
2x, or higher. CD was able to observe that TMAB-CS had the most significant interaction 
with DDD when compared to the interactions of the chitosan derivatives. Finally, yeast 
growth assays were conclusive in determining that TEPB-CS was able to inhibit yeast 
growth better than ammonium compounds, and will be used in future studies with 
mammalian cells to observe their interaction. 
Future work will examine the cytotoxicity of the compounds made in this work as 
well as the transfection efficiency with regard to mammalian cells.  
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APPENDICES 
Appendix A. NMR  
 
The 1H NMR Spectra was collected using a Varian 400 MHz NMR spectrometer 
and plotted using Varian VNMRJ software. All the spectra presented in this appendix 
displays a ppm range of -2-14 to display the isolation of each compound free of starting 
materials or impurities. The red lines indicate the range of which integration occurred and 
their values presented in red under the spectra. Thee ppm values of all signals are 
indicated in blue are located above the spectra. 
 
 
 
  
Appendix A-1. 1H NMR spectrum of (1-Carboxymethyl) trimethylammonium chloride. 4.33 
(2H, -CH2N
+(CH3)3), 3.19 (9H, -N
+(CH3)3), DMSOd6 
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Appendix A-2. 1H NMR spectrum of (1-Carboxymethyl) triethylammonium chloride. 
DMSOd6: 4.18 (2H, -CH2N
+(CH2CH3)3), 3.44 (6H, -N
+(CH2CH3)3), 1.16 (9H, -
N+(CH2CH3)3. 
 
Appendix A-3. 1H NMR spectrum of (1-Carboxymethyl) tripropylammonium chloride. 
DMSOd6: 3.29 (2H, HO2CCH2-), 2.96 (6H, -N
+(CH2CH2CH3)3), 1.62 (6H, -
N+(CH2CH2CH3)3), 0.85 (9H, -N
+(CH2CH2CH3)3 
  
67 
 
 
Appendix A-5. 1H NMR spectrum of (3-Carboxypropyl) trimethylammonium chloride. 
12.31 (1H, HO2CCH2-), 3.01 (9H, -CH2CH2CH2N(CH3)3), 2.71 (2H, -
CH2CH2CH2N
+(CH3)3), 2.26 (2H, -CH2CH2CH2N
+(CH3)3 ), 1.88 (2H, -
CH2CH2CH2N
+(CH3)3 
 
Appendix A-4. 1H NMR spectrum of (1-Carboxymethyl) triethylphosphonium chloride. 3.75 
(2H, -H2P
+(CH2CH3)3), 2.30 (6H, HO2CCH2 P
+(CH2CH3)3), 1.10 (9H, -P
+(CH2CH3)3 
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Appendix A-6. 1H NMR spectrum of (3-Carboxypropyl) triethylammonium chloride. 12.31 
(1H, HO2CCH2-), 3.20 (9H, -N
+(CH2CH3)3), 3.07 (2H, -CH2N
+(CH2CH3)3), 2.31 (2H, -
CH2CH2CH2N
+-), 1.75 (2H, -CH2CH2CH2N
+-), 1.13 (2H, -N+(CH2CH2)3 
 
Appendix A-7. 1H NMR spectrum of (3-Carboxypropyl) tripropylammonium chloride. 12.31 
(1H, HO2CCH2-), 3.20 (9H, -N
+(CH2CH2CH3)3), 3.07 (2H, -CH2N
+(CH2CH2CH3)3), 2.31 (2H, 
-CH2CH2CH2N
+-), 1.75 (2H, -CH2CH2CH2N
+- ), 1.13 (2H, -N
+(CH2CH2CH3 ) 
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Appendix A-8. 1H NMR spectrum of (2-Carboxyethyl) triethylphosphonium chloride. 12.58 
(1H, HO2CCH2-), 2.55 (2H, -CH2CH2P
+-), 2.39 (2H, -CH2 P
+(CH2CH3)3), 2.23 (6H, -
P+(CH2CH3)3), 1.08 (9H, -P
+(CH2CH3)3 
 
Appendix A-9. 1H NMR spectrum of (3-Carboxypropyl) triethylphosphonium chloride. 
12.16 (1H, HO2CCH2CH2-), 2.36 (2H, HO2CCH2CH2CH2-), 2.26 (2H, -CH2 P
+(CH2CH3)3), 
2.22 (6H, -P+(CH2CH3)3), 1.67 (2H, -CH2CH2P
+(CH2CH3)3), 1.08 (9H, -P
+(CH2CH3)3 
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Appendix A-10. 1H NMR spectrum of 95% Chitosan. 4.45 (1H, anomeric H), 3.80-3.30 (6H, 
C2-C6 H’s). 
 
Appendix A-11. 1H NMR spectrum of 2-(N-4-trimethylammonium chloride) butanamide 
chitosan. 4.45 (1H, anomeric H), 3.80-3.30 (6H, C2-C6 H’s), 3.21 (2H, -CH2CH2N+(CH3)), 
2.98 (9H, -CH2CH2N
+(CH3)), 2.29 (2H, -OCH2CH2CH2N
+(CH3)), 1.96 (2H, -
CH2CH2N
+(CH3). 
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Appendix A-13. 1H NMR spectrum of 2-(N-4-tripropylammonium chloride) butanamide 
chitosan. 4.48 (1H, C1-Anomaric H), 4.0-3.25 (6H, C2-C6 H’s), 3.04 (6H, -N+(CH2CH2CH3)3), 
2.74 (2H, -CH2N
+(CH2CH2CH3)3) , 2.26 (2H, -CH2CH2CH2N
+-), 1.85 (2H, -CH2CH2 N
+-), 
1.55 (6H, -N+(CH2CH2CH3)3), 0.79 (9H, -N
+(CH2CH2CH3)3 
 
Appendix A-12. 1H NMR spectrum of 2-(N-4-triethylammonium chloride) butanamide 
chitosan. 4.43 (1H, anomeric H), 4.0-3.25 (6H, C2-C6 H’s), 3.15 (2H, -N+(CH2CH3)3), 3.04 
(9H, -CH2CH2N
+(CH2CH3)3), 2.66 (1-2H, -2H-NHCOCH2-), 2.28 (2H, -OCH2CH2CH2 N
+-, 
1.84 (2H, -CH2CH2N
+( CH2CH3)3, 1.11 (2H, -CH2CH2N
+( CH2CH3)3 
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Appendix A-15. 1H NMR spectrum of 2-(N-4-triethylphosphonium chloride) butanamide 
chitosan. 4.82 (1H, anomeric H), 4.0-2.66 (6H, C2-C6 H’s ,2H-NH), 2.35 (2H, -
OCH2CH2CH2N
+ -), 2.07 (6H, -N+(CH2CH3)3) , 2.07 (2H, -CH2N
+(CH2CH3)3), 1.75 (2H, -
CH2CH2N
+(CH2CH3)3), 1.08 (9H, - N
+(CH2CH3)3 
 
Appendix A-14. 1H NMR spectrum of 2-(N-3-triethylphosphonium chloride) 
propionamide chitosan. 4.48 (1H, anomeric H), 4.0-2.66 (6H, C2-C6 H’s,2H-NH), 2.55 
(2H, -CH2CH2N
+(CH2CH3)3), 2.38 (2H, -CH2N
+(CH2CH3)3) , 2.11 (6H, -
CH2N
+(CH2CH3)3), 1.09 (9H, -CH2 N
+(CH2CH3)3 
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Appendix A-16. 1H NMR spectrum of 2-(N-5-triphenylphosphonium chloride) 
pentanamide chitosan. 7.65-7.50 (15H, P+Ph3-CH2CH2-), 4.39 (1H, anomeric H), 
4.0-2.66 (6H, C2-C6 H’s ,2H-NH), 3.13 (2H, P+Ph3-CH2CH2-), 2.16 (2H, P+Ph3-
CH2CH2CH2CH2-), 1.60 (4H, P
+Ph3-CH2CH2CH2-) 
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Appendix B. IR  
 
The IR Spectra was collected using a Bruker Vertex 70 FT-IR spectrometer and 
plotted using Bruker OPUS 7.5 software. All the spectra presented in this appendix 
displays a wavenumber (cm-1) range of 400-4000 to display the amide I, amide II, C-O, 
N-H, C-H, C-N+, and C-P+ stretch peaks found on coupled chitosan derivatives. The 
wavenumber (cm-1) values of all signals are indicated in black are located below the 
spectra. 
 
  
Appendix B-1. IR spectrum of 95% DA Chitosan 
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Appendix B-2. IR spectrum of 2-(N-4-trimethylammonium chloride) 
butanamide chitosan. 
Appendix B-3. IR spectrum of 2-(N-4-triethylammonium chloride) 
butanamide chitosan. 
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Appendix B-4. IR spectrum of 2-(N-4-tripropylammonium chloride) butanamide 
chitosan. 
 
Appendix B-5. IR spectrum of 2-(N-3-triethylphosphonium chloride) propionamide 
chitosan 
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Appendix B-6. IR spectrum of 2-(N-4-triethylphosphonium chloride) butanamide 
chitosan 
 
Appendix B-7. IR spectrum of 2-(N-5-triphenylphosphonium chloride) 
pentanamide chitosan 
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Appendix B-9. IR spectrum of 2-(N-4-triethylphosphonium chloride) butanamide 
chitosan 
 
Appendix B-8. IR spectrum of 2-(N-4-triethylphosphonium chloride) butanamide 
mPEG-g-chitosan  
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Appendix B-10. IR spectrum of 2-(N-5-triphenylphosphonium chloride) pentanamide 
chitosan 
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Appendix C. TGA and DTG  
 
TGA (green) and DTG (blue) was conducted to examine the change in stability of 
chitosan’s polymer chain after coupling of carboxy ligands. The TGA and DTG Spectra 
were collected using a TA Instrument Q600 Thermogravimetric Analyzer and plotted 
using TA Universal Analyzer software. All the spectra presented in this appendix 
displays weight % (green), and 1st Derivative weight % (blue) of all chitosan derivatives. 
The beginning and end of each degradation phase are marked along the TGA (green) 
spectra. 
  
Appendix C-1. TGA and DTG analysis of 95% DA Chitosan 
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Appendix C-3. TGA-DTG analysis of 2-(N-4-triethylammonium 
chloride) butanamide chitosan 
 
Appendix C-2. TGA-DTG 2-(N-4-trimethylammonium chloride) 
butanamide chitosan 
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Appendix C-4. TGA-DTG analysis of 2-(N-4-tripropylammonium 
chloride) butanamide chitosan 
 
Appendix C-5. TGA-DTG analysis of 2-(N-3-triethylphosphonium 
chloride) propionamide chitosan 
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Appendix C-6. TGA-DTG analysis of 2-(N-4-triethylphosphonium 
chloride) butanamide chitosan 
 
Appendix C-7. TGA-DTG analysis of 2-(N-5-triphenylphosphonium 
chloride) pentanamide chitosan 
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 Appendix D. Agarose Gel Electrophoresis  
 
 Agarose gel electrophoresis was conducted to examine complexation affinity of 
all cationic chitosan derivatives. The images were visualized using ethidium bromide, 
short-wave UV light, and Microsoft Windows image capturing software. All chitosan 
derivatives examined with Drew Dickerson Dodecamer DNA are shown in this appendix 
using 2% agarose gel. Wells are in charge ratios of 1) 16x, 2) 8x, 3) 4x, 4) 2x, 5) 1x, 6) 
0.5x, 7) 0.25x, 8) Control  
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 Appendix D-1. Agarose gel electrophoresis result of TMAB-CS. Wells are in charge 
ratios of 1) 16, 2) 8, 3) 4, 4) 2, 5) 1, 6) 0.5, 7) 0.25, 8) Control 
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Appendix D-2. Agarose gel electrophoresis result of TEAB-CS. Wells are in charge 
ratios of 1) 16, 2) 8, 3) 4, 4) 2, 5) 1, 6) 0.5, 7) 0.25, 8) Control 
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 Appendix D-3. Agarose gel electrophoresis result of TPAB-CS. Wells are in charge 
ratios of 1) 16, 2) 8, 3) 4, 4) 2, 5) 1, 6) 0.5, 7) 0.25, 8) Control 
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Appendix D-4 Agarose Gel of Agarose gel electrophoresis result of TEPPr-CS. Wells 
are in charge ratios of 1) 16, 2) 8, 3) 4, 4) 2, 5) 1, 6) 0.5, 7) 0.25, 8) Control 
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 Appendix D-5. Agarose Gel of Agarose gel electrophoresis result of TEPB-CS. Wells 
are in charge ratios of 1) 16, 2) 8, 3) 4, 4) 2, 5) 1, 6) 0.5, 7) 0.25, 8) Control 
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 Appendix D-6. Agarose Gel of Agarose gel electrophoresis result of TPPP-CS. Wells 
are in charge ratios of 1) 16, 2) 8, 3) 4, 4) 2, 5) 1, 6) 0.5, 7) 0.25, 8) Control 
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Appendix D-7. Agarose Gel of Agarose gel electrophoresis result of TEAB-mPEG-
CS. Wells are in charge ratios of 1) 16, 2) 8, 3) 4, 4) 2, 5) 1, 6) 0.5, 7) 0.25, 8) Control 
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Appendix D-8. Agarose Gel of Agarose gel electrophoresis result of TEPB-mPEG-CS. 
Wells are in charge ratios of 1) 16, 2) 8, 3) 4, 4) 2, 5) 1, 6) 0.5, 7) 0.25, 8) Control 
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Appendix D-9. Agarose Gel of Agarose gel electrophoresis result of TEPB-mPEG-
CS. Wells are in charge ratios of 1) 16, 2) 8, 3) 4, 4) 2, 5) 1, 6) 0.5, 7) 0.25, 8) Control 
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Appendix E. Circular Dichroism (CD) 
 
Circular Dichroism was conducted to examine changes in conformational states 
and complexation affinity of all cationic chitosan derivatives using DDD DNA. CD 
spectra were obtained using Jasco J-815 spectrometer coupled with PFD-425s Single 
Position Peltier. All spectra in this appendix were gathered using cationic chitosan 
derivatives with B-form DNA and evaluated between 210-300 nm. 
 
 
  
Appendix E-1. CD spectrum of 2-(N-4-trimethylammonium chloride) butanamide 
chitosan was examine using charge ratios of 1x, 2x, 4x, 8x, 16x, 32x, 42x.  
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Appendix E-2. CD spectrum of 2-(N-4-triethylammonium chloride) butanamide 
chitosan was examine using charge ratios of 1x, 2x, 4x, 8x, 16x, 32x, 42x.  
 
Appendix E-3. CD spectrum of 2-(N-4-propylammonium chloride) butanamide 
chitosan was examine using charge ratios of 1x, 2x, 4x, 8x, 16x, 32x, 42x. 
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Appendix E-4. CD spectrum of 2-(N-3-triethylphosphonium chloride) propionamide 
chitosan was examine using charge ratios of 1x, 2x, 4x, 8x, 16x, 32x, 42x.  
 
Appendix E-5. CD spectrum of 2-(N-4-triethylphosphonium chloride) butanamide 
chitosan was examine using charge ratios of 1x, 2x, 4x, 8x, 16x, 32x, 42x.  
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Appendix E-6. CD spectrum 2-(N-4-triethylammonium chloride) butanamide mPEG-
g-chitosan was examine using charge ratios of 1x, 2x, 4x, 8x, 16x, 32x, 42x.  
 
Appendix E-7. CD spectrum 2-(N-4-triethylphosphonium chloride) butanamide 
mPEG-g-chitosan was examine using charge ratios of 1x, 2x, 4x, 8x, 16x, 32x, 42x.  
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Appendix F. Fluorescence Microscopy  
 
To evaluate chitosan derivatives ability to be internalized by yeast they were 
examined using fluorescence microscopy studies. Chitosan derivatives were tagged with 
FITC, incubated with yeast cells, then washed and placed on a slide and examined. All 
chitosan derivative images obtained were digitally colored using intensity heat mapping 
and are displayed in this appendix.  
 
 
 
Appendix F-1. Fluorescence microscopy image of FITC tagged 2-(N-4-
trimethylammonium chloride) butanamide chitosan with yeast cells 
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Appendix F-2. Fluorescence microscopy image of FITC tagged 2-(N-4-
triethylammonium chloride) butanamide chitosan with yeast cells 
Appendix F-3. Fluorescence microscopy image of FITC tagged 2-(N-4-
tripropylammonium chloride) butanamide chitosan with yeast cells 
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Appendix F-4. Fluorescence microscopy image of FITC tagged 2-(N-4-
triethylphosphonium chloride) butanamide chitosan with yeast cells 
Appendix F-5. Fluorescence microscopy image of FITC 2-(N-4-triethylammonium 
chloride) butanamide mPEG-g-chitosan with yeast cells 
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Appendix F-6. Fluorescence microscopy image of FITC 2-(N-4-triethylphosphonium 
chloride) butanamide mPEG-g-chitosan with yeast cells. 
Appendix F-7. Fluorescence microscopy image of 2-(N-5-triphenylphosphonium 
chloride) pentanamide mPEG-g-chitosan with yeast cells 
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Appendix G. Yeast Growth Assays 
 
Chitosan derivatives antifungal properties were evaluated using freshly inoculated 
yeast cells to test for potential growth inhibition. All cells were placed into a 96 well 
plate with various concentration of chitosan derivatives ranging from 0.1-1000 µg/mL 
and examined over 24 hours with their OD read every 10 minutes. The spectra shown in 
this appendix has concentrations of 0, 0.1, and 5 µg/mL, all other concertation’s 
completely inhibited growth.  
  
Appendix G-1. 2-(N-4-trimethylammonium chloride) butanamide chitosan’s Yeast 
Growth Assay over the period of 24 hours 
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Appendix G-2. 2-(N-4-triethylammonium chloride) butanamide chitosan’s Yeast 
Growth Assay over the period of 24 hours 
Appendix G-3. 2-(N-4-tripropylammonium chloride) butanamide chitosan’s Yeast 
Growth Assay over the period of 24 hours 
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Appendix G-4. 2-(N-4-triethylphosphonium chloride) butanamide chitosan’s Yeast 
Growth Assay over the period of 24 hours 
